Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (171-180 of 380) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Autologous stem-cell transplantation in patients with HIV-related lymphomaPascual Balsalobre, José L Díez-Martín, Alessandro Re, et al.
Haematologica|October 14, 2011
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Carme Canals, Reyes Arranz, et al.
Hemasphere|June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-upDennis A Eichenauer, Marc André, Peter Borchmann, et al.
Disease Models & Mechanisms|May 14, 2021
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studiesLourdes Farre, Gabriela Sanz, Neus Ruiz-Xivillé, et al.
British Journal of Haematology|October 2, 2009
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationIrit Avivi, Silvia Montoto, Carme Canals, et al.
Blood Advances|August 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party studySimon Renders, Maud Ngoya, Herve Finel, et al.
Blood Advances|December 14, 2021
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, et al.
Medicina Clinica|October 30, 2009
[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]Ramón García-Sanz, Adrián Alegre, Francisco Javier Capote, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 38

Showing results (171-180 of 380) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Autologous stem-cell transplantation in patients with HIV-related lymphomaPascual Balsalobre, José L Díez-Martín, Alessandro Re, et al.
Haematologica|October 14, 2011
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Carme Canals, Reyes Arranz, et al.
Hemasphere|June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-upDennis A Eichenauer, Marc André, Peter Borchmann, et al.
Disease Models & Mechanisms|May 14, 2021
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studiesLourdes Farre, Gabriela Sanz, Neus Ruiz-Xivillé, et al.
British Journal of Haematology|October 2, 2009
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationIrit Avivi, Silvia Montoto, Carme Canals, et al.
Blood Advances|August 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party studySimon Renders, Maud Ngoya, Herve Finel, et al.
Blood Advances|December 14, 2021
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, et al.
Medicina Clinica|October 30, 2009
[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]Ramón García-Sanz, Adrián Alegre, Francisco Javier Capote, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 38